Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

By D. Rollison, N. Howlader, Martyn T. Smith, S. Strom, W. Merritt, L. Ries, B. Edwards, A. List. Blood, 2008

647 citations recorded by the source corpus.

Subfields: Genetics, Hematology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/e3746794a3819647be508bee108b8f6744e65875

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Malcovati
2. E. Hellström-Lindberg
3. D. Bowen
4. U. Germing
5. J. Čermák
6. G. Sanz
7. L. Adès
8. P. Fenaux

Citations in the corpus

• Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. (2013, background): “The incidence rate of these conditions is about 5 cases per 100,000 persons per year in the general population, but increases to 20 to 50 cases per 100,000 persons per year after 60 years of age.(2-7) This means that approximately 25,000 new cases are expected in Europe each year.”